Trial Outcomes & Findings for Prospective Evaluation of 14F Thal Tube vs 28 French Chest Tube for Hemothorax and Use of Maximum Barrier Precautions (NCT NCT03167723)

NCT ID: NCT03167723

Last Updated: 2023-03-29

Results Overview

Number of Participants with Retained hemothorax requiring an additional intervention, either video-assisted thoracoscopic surgery (VATS) or additional thoracostomy tube placement.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

193 participants

Primary outcome timeframe

90 days

Results posted on

2023-03-29

Participant Flow

Excluded (n=84) Hemodynamic instability (n=36) Chest tube placed at outside facility (n=12) Multiple chest tube placement (n=10) Declined to participate (n=1) Not meet inclusion criteria (n=6) Other reasons (n=19)

Participant milestones

Participant milestones
Measure
28 French Chest Tube for Hemothorax
28 French straight chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax Chest tube placement: Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
14 French Chest Tube for Hemothorax
14 French thal chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax Chest tube placement: Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
Overall Study
STARTED
55
54
Overall Study
COMPLETED
51
48
Overall Study
NOT COMPLETED
4
6

Reasons for withdrawal

Reasons for withdrawal
Measure
28 French Chest Tube for Hemothorax
28 French straight chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax Chest tube placement: Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
14 French Chest Tube for Hemothorax
14 French thal chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax Chest tube placement: Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
Overall Study
Protocol Violation
4
6

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
28 French Chest Tube for Hemothorax
n=55 Participants
28 French straight chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax Chest tube placement: Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
14 French Chest Tube for Hemothorax
n=54 Participants
14 French thal chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax Chest tube placement: Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
Total
n=109 Participants
Total of all reporting groups
Age, Continuous
49.9 years
n=55 Participants
46.5 years
n=54 Participants
49 years
n=109 Participants
Sex: Female, Male
Female
17 Participants
n=55 Participants
15 Participants
n=54 Participants
32 Participants
n=109 Participants
Sex: Female, Male
Male
38 Participants
n=55 Participants
39 Participants
n=54 Participants
77 Participants
n=109 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Injury Severity Score - score that ranges from 3 (least) to 75 (most) injured
17 units on a scale
n=55 Participants
18 units on a scale
n=54 Participants
17 units on a scale
n=109 Participants

PRIMARY outcome

Timeframe: 90 days

Number of Participants with Retained hemothorax requiring an additional intervention, either video-assisted thoracoscopic surgery (VATS) or additional thoracostomy tube placement.

Outcome measures

Outcome measures
Measure
28 French Chest Tube for Hemothorax
n=51 Participants
28 French straight chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax Chest tube placement: Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
14 French Chest Tube for Hemothorax
n=48 Participants
14 French thal chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax Chest tube placement: Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
Number of Participants With Retained Hemothorax Following Initial Chest Tube Placement Requiring Intervention
51 Number of Participants
48 Number of Participants

SECONDARY outcome

Timeframe: 90 days

Number of days with chest tube placement

Outcome measures

Outcome measures
Measure
28 French Chest Tube for Hemothorax
n=51 Participants
28 French straight chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax Chest tube placement: Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
14 French Chest Tube for Hemothorax
n=48 Participants
14 French thal chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax Chest tube placement: Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
Duration of Chest Tube Placement.
3.9 days
Interval 2.6 to 5.3
3.9 days
Interval 2.8 to 5.8

SECONDARY outcome

Timeframe: 90 days

Number of weeks spent in hospital

Outcome measures

Outcome measures
Measure
28 French Chest Tube for Hemothorax
n=51 Participants
28 French straight chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax Chest tube placement: Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
14 French Chest Tube for Hemothorax
n=48 Participants
14 French thal chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax Chest tube placement: Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
Number of Participants Stratified by Length of Hospitalization Stay
1 Week
20 Number of Participants
15 Number of Participants
Number of Participants Stratified by Length of Hospitalization Stay
2 Weeks
19 Number of Participants
15 Number of Participants
Number of Participants Stratified by Length of Hospitalization Stay
3 Weeks
7 Number of Participants
6 Number of Participants
Number of Participants Stratified by Length of Hospitalization Stay
> or = 4 Weeks
5 Number of Participants
12 Number of Participants

SECONDARY outcome

Timeframe: 90 days

Assessed with 0-10 numeric pain rating scale - the higher the number, the more severe the pain

Outcome measures

Outcome measures
Measure
28 French Chest Tube for Hemothorax
n=51 Participants
28 French straight chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax Chest tube placement: Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
14 French Chest Tube for Hemothorax
n=48 Participants
14 French thal chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax Chest tube placement: Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
Change in Subjective Pain Scores From Baseline at 90 Days
0 units on a scale
Interval -1.0 to 2.0
0 units on a scale
Interval -2.0 to 2.0

SECONDARY outcome

Timeframe: 90 days

determined by vital signs: temperature, heart rate, blood pressure, oxygen saturation (Systolic Blood Pressure \<90mm Hg)

Outcome measures

Outcome measures
Measure
28 French Chest Tube for Hemothorax
n=51 Participants
28 French straight chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax Chest tube placement: Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
14 French Chest Tube for Hemothorax
n=48 Participants
14 French thal chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax Chest tube placement: Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
Hemodynamic Stability Post-insertion
2 Number of Participants
1 Number of Participants

SECONDARY outcome

Timeframe: 5 Minutes

Milliliters of chest tube drainage at 5 minutes

Outcome measures

Outcome measures
Measure
28 French Chest Tube for Hemothorax
n=51 Participants
28 French straight chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax Chest tube placement: Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
14 French Chest Tube for Hemothorax
n=48 Participants
14 French thal chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax Chest tube placement: Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
Initial Drainage From Chest Tube at 5 Minutes
150 mL
Interval 60.0 to 500.0
100 mL
Interval 3.5 to 350.0

SECONDARY outcome

Timeframe: 90 days

Number of Tube specific complications: Air leak, tube malposition, \& tube migration

Outcome measures

Outcome measures
Measure
28 French Chest Tube for Hemothorax
n=51 Participants
28 French straight chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax Chest tube placement: Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
14 French Chest Tube for Hemothorax
n=48 Participants
14 French thal chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax Chest tube placement: Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
Tube Specific Complications: Air Leak, Tube Malposition, & Tube Migration
7 Ocurrences
5 Ocurrences

SECONDARY outcome

Timeframe: 90 days

Number of days until radiographic resolution of pneumothorax/hemothorax/hemopneumothorax

Outcome measures

Outcome measures
Measure
28 French Chest Tube for Hemothorax
n=51 Participants
28 French straight chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax Chest tube placement: Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
14 French Chest Tube for Hemothorax
n=48 Participants
14 French thal chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax Chest tube placement: Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
Time to Radiographic Resolution of Pneumothorax/Hemothorax/Hemopneumothorax
0.5 days
Interval 0.1 to 2.7
1 days
Interval 0.1 to 2.7

SECONDARY outcome

Timeframe: 90 days

Number of Participants with Recurrent pneumothorax/hemothorax/hemopneumothorax after tube removal

Outcome measures

Outcome measures
Measure
28 French Chest Tube for Hemothorax
n=51 Participants
28 French straight chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax Chest tube placement: Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
14 French Chest Tube for Hemothorax
n=48 Participants
14 French thal chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax Chest tube placement: Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
Recurrent Pneumothorax/Hemothorax/Hemopneumothorax After Tube Removal
5 participants
1 participants

SECONDARY outcome

Timeframe: 90 days

Number of Participants readmitted for chest tube related complications

Outcome measures

Outcome measures
Measure
28 French Chest Tube for Hemothorax
n=51 Participants
28 French straight chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax Chest tube placement: Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
14 French Chest Tube for Hemothorax
n=48 Participants
14 French thal chest tube placed for non-emergent drainage of hemothorax or hemopneumothorax Chest tube placement: Placing tube thoracostomy for hemothorax or hemopneumothorax utilizing maximal barrier precautions.
Readmission for Chest Tube Related Complications
9 participants
4 participants

Adverse Events

28 French Chest Tube for Hemothorax

Serious events: 0 serious events
Other events: 0 other events
Deaths: 2 deaths

14 French Chest Tube for Hemothorax

Serious events: 0 serious events
Other events: 0 other events
Deaths: 2 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Bradley Thomas MD

Atrium Health Wake Forest

Phone: 704-355-3176

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place